
ESMO issues first recommendations on using next-generation sequencing for advanced cancers
Recommendations on the use of next-generation sequencing (NGS) for patients with metastatic cancers are being…
Recommendations on the use of next-generation sequencing (NGS) for patients with metastatic cancers are being…
We’re Not Really Where We Thought We Would Be Rachael Babin is chatting again…
Shortages of essential cancer medicines have a direct impact on patient care across Europe. To…
The European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO),…
ESMO, the leading professional organisation for medical oncology, shares concerns expressed in a scientific paper…